Category Archives: Health

Latest From
Health

Writing at the White House blog, CDC Director Dr. Tom Frieden says his colleagues working in the CDC’s birth defect center tell him they’ve never seen such cause for alarm. “It’s been more than 50 years since we’ve discovered a birth defect linked to a virus – and never before have we seen this result from a mosquito bite.” While you can avoid travel to areas where Zika is spreading [map], there is no vaccine Read More >

The Zika virus epidemic continues to rage on. Just today, the WHO advised people in Zika affected countries (much of Latin America and the Caribbean) to consider delaying pregnancy, and emerging evidence suggests a broader range of possible complications for babies born to women infected with the virus than was first thought. Solutions are urgently needed, and biotechnology companies are hard at work to contribute. During a Wednesday at the 2016 BIO International Convention, attendees heard from Read More >

The strategic venture arms of major biopharma companies like AbbVie, Amgen, Johnson & Johnson and Pfizer offer unique value propositions to early-stage companies and have the flexibility to shape unique deal structures for advancing these partnerships beyond traditional corporate venture capital models. Speakers at a 2016 BIO International Convention panel titled “Strategic Venture Investing by Large Pharma: Is ‘Smart Money’ Right for Your Company?” provided their about how these venture arms fuel innovation in the Read More >

Today’s “Nailed It! Rock Star Panel,” sponsored by Johnson & Johnson Innovation/JLABS, featured three company CEOs who have spent their careers as leaders and executives across the biopharmaceutical industry. Each of the panelists spent time in both large pharma companies and emerging businesses before taking the leap and using their experience to lead a small or start-up company. The panel focused on, essentially, how to be a CEO – the panelists shared tips on everything Read More >

New hepatitis C medications with exceptionally high cure rates have significantly improved treatment, while also posing a challenge for the healthcare system because the cost of the medications are higher in the short run than other medications. As more curative therapies for different conditions come to market, the healthcare system will need to manage the concentration of upfront expenses in a sustainable manner. A Super Session panel at the 2016 BIO International Convention examined this Read More >